Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Doravirine-associated resistance mutations in antiretroviral therapy naïve and experienced adults with HIV-1 subtype C infection in Botswana

Journal of Global Antimicrobial Resistance(2022)10.1016/j.jgar.2022.08.008Source: DataRank Database

Doravirine-associated resistance mutations in antiretroviral therapy naïve and experienced adults with HIV-1 subtype C infection in Botswana is a research paper published in Journal of Global Antimicrobial Resistance (2022). On theSindex it has a DataRank of 0. It has been cited 4 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access4 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (19 grants)Impact (FWCI 0.39)OA: goldTopics (61)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (24)

Sekgabo Seselamarumo,Kaelo K. Seatla ORCID,Wonderful T. Choga ORCID,Blessing Bakae ORCID,Dorcas Maruapula ORCID

Live enrichment

PubMed:35973671 PMC:PMC9750894 OpenAlex:https://openalex.org/W4291221773

Bill and Melinda Gates Foundation

Grant: INV-033558

National Institutes of Health

Grant: U41HG006941

European Commission

Grant: CSA2020NoE-3104 TESAIII CSA2020NoE

Centers for Disease Control and Prevention

Grant: U01 GH000447

Centers for Disease Control and Prevention

Grant: U2G GH001911

Fogarty International Center

Grant: 5D43TW009610

European & Developing Countries Clinical Trials Partnership (EDCTP)

Grant: CSA2020NoE-3104

FIC NIH HHS

Grant: D43 TW009610

NIAID NIH HHS

Grant: K24 AI131928

National Institutes of Health

Grant: 5U2GGH001911-03

GH16-002, Botswana: Impact Evaluation of Combination HIV Prevention Interventions

National Institutes of Health

Grant: 5D43TW009610-03

Fogarty HIV Research Training Program for Low and Middle-Income Countries

Wellcome Trust

Grant: unidentified

unidentified

National Institutes of Health

Grant: 5K24AI131928-05

Addressing Major HIV Prevention and Health Outcomes Questions in an Era of Universal ART: Mentoring in a Community-Randomized Trial

National Institutes of Health

Grant: 3U41HG006941-02S2

H3ABioNet: a sustainable African Bioinformatics Network for H3Africa

National Institutes of Health

Grant: 5U01GH000447-04

Impact Evaluation of Combination HIV Prevention Interventions in Botswana

Wellcome Trust

PEPFAR

Wellcome Trust

FWCI

0.39

Citation Percentile

0.6%

Citation Trend

2024

2025

2026

goldLicense: cc-by

journalhttps://doi.org/10.1016/j.jgar.2022.08.008

publisherhttps://doi.org/10.1016/j.jgar.2022.08.008

publisherhttps://api.elsevier.com/content/article/PII:S2213716522001989?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2213716522001989?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35973671

Fields of Study

HIV/AIDS drug development and treatmentPneumocystis jirovecii pneumonia detection and treatmentHIV Research and Treatment03 medical and health sciences0302 clinical medicineAdultHumansHIV-1Anti-HIV AgentsDrug Resistance, ViralCross-Sectional StudiesRetrospective StudiesBotswanaHIV InfectionsMutationPyridonesTriazoles

MeSH Terms

AdultBotswanaCross-Sectional StudiesHumansMutationPyridonesRetrospective StudiesTriazolesHIV-1HIV InfectionsAnti-HIV AgentsDrug Resistance, Viral

Keywords

Confidence intervalDrug resistanceMedicineInternal medicineAntiretroviral therapyHuman immunodeficiency virus (HIV)PopulationViral loadRetrospective cohort studyVirologyGeneticsBiologyBotswanaDrug Resistance MutationsHiv-1cDoravirineAntiretroviral (Art) ExperiencedAntiretroviral (Art) NaiveAdultAnti-HIV AgentsPyridonesHIV InfectionsTriazolesMicrobiologyQR1-502ArticleCross-Sectional StudiesDrug Resistance, ViralMutationHIV-1HumansRetrospective Studies

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Doravirine-associated resistance mutations in antiretroviral therapy naïve and experienced adults with HIV-1 subtype C infection in Botswana

FAIR Checklist

Authors (24)

Funding (19 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)